[1] |
FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong.
Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.
|
[2] |
LI Xingren, SHEN Aizong, SU Dan.
Evaluation of the rationality of proton pump inhibitors in preventing perioperative stress related mucosal disease in biliary and pancreatic surgery
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1022-1026.
|
[3] |
CHEN Jie, QIN Kan.
Evaluation of individualized parenteral nutrition delivery
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 812-816.
|
[4] |
LIU Jing, XIA Liang, ZHANG Shijie.
Pharmaceutical care of a patient with acute pancreatitis complicated with multiple drug allergy undergoing drug stimulation test
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 822-824.
|
[5] |
SU Su, WU Shiqi, ZHANG Qingxia, YAN Suying.
Pharmaceutical care of a patient with indapamide-induced agranulocytosis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1282-1285.
|
[6] |
ZHUANG Hongyan, ZANG Yannan, LIU Shanshan, NIU Mengxi, FANG Meng, YIN Dongqing, GUO Wei.
Analysis of neuropsychiatric adverse reactions caused by zolpidem
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 889-892.
|
[7] |
WEI Hongtao, SHEN Su, LI Dandan, LIAO Yin.
Pareto chart analysis of 705 problematic prescriptions in neurology
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 900-903.
|
[8] |
YUAN Xiaolong, WAN Qihua, TAO Donghong, QI Hao, WANG Aixia.
Pharmaceutical care of a severely poisoned patient with methotrexate tablets
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 924-928.
|
[9] |
SUN Xuelin, ZHANG Pan, HU Xin.
Pharmaceutical care of a case of severe ulcerative colitis treated with vedolizumab
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 782-785.
|
[10] |
TANG Jingya.
Pharmaceutical care by a clinical pharmacists in the treatment of parenteral nutrition related hepatic damage: a case report
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 786-788.
|
[11] |
YANG Baochun, SUN Xin, YANG Xin, WU Lin, WANG Liping.
Pharmaceutical care for a patient with urinary tract infection and drug fever
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 572-573.
|
[12] |
CHEN Fangfang, ZHANG Hongxu.
Pharmacy practice during the treatment of primary central nervous system lymphoma with high dose methotrexate
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 446-449.
|
[13] |
XU Zhe, JU Ping, LUO Qi, YANG Huan, WANG Yang.
930 cases of adverse drug reactions induced by antibacterial drugs in children
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 317-321.
|
[14] |
LI Youjia, XIE Jiao, YAO Hongyi, JI Cheng.
Pharmaceutical care of one case of hypoparathyroid cardiomyopathy
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1254-1257.
|
[15] |
ZHUANG Hongyan, LIU Shanshan, GUO Wei, XUE Chunmiao, HE Yue, ZHAO Yan.
Chinese and western medicine pharmaceutical care for one diabetic foot patient with multiple complications
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 103-106.
|